Therapeutic application of vascular diseases by novel angiotensin II receptor signal regulating molecule
新型血管紧张素II受体信号调节分子在血管疾病治疗中的应用
基本信息
- 批准号:15390247
- 负责人:
- 金额:$ 9.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The cardiovascular actions of angiotensin II (Ang II) are mainly mediated by the Ang II type 1 (AT_1) receptor. We cloned a novel AT_1 receptor-associated protein (ATRAP) using a yeast two-hybrid screening system. To explore the role of ATRAP in vascular remodeling, we developed transgenic mice for mouse ATRAP-cDNA, and examined remodeling after inflammatory vascular injury induced by polyethylene-cuff placement. In ATRAP transgenic (ATRAP-Tg) mice, ATRAP mRNA was increased 3- to 4-fold in the heart, aorta and femoral artery. ATRAP-Tg mice showed no significant change in body weight, systolic blood pressure, heart rate and heart-to-body weight ratio. However, cell proliferation and neointimal formation in the injured artery were attenuated in ATRAP-Tg mice. The increase in NADPH oxidase activity and the expression of p22^<phox>, an NADH/NADPH oxidase subunit, after cuff placement was also attenuated in ATRAP-Tg mice. Moreover, activation of extracellular signal-regulated kinase (ERK), signal transducer and activator of transcription (STAT)1, and STAT3 after cuff placement were significantly reduced in ATRAP-Tg mice. In addition, we observed that cardiac hypertrophy induced by pressure-overload and Ang II infusion was attenuated in ATRAP-Tg mice, and that pressor response to Ang II was also decreased in ATRAP-Tg mice. These results suggest that ATRAP plays an important role in cardiovascular remodeling as a negative regulator.
血管紧张素II(Ang II)的心血管作用主要由血管紧张素II 1型(AT_1)受体介导。我们利用酵母双杂交筛选系统克隆了一个新的AT1受体相关蛋白(ATRAP)。为了探讨ATRAP在血管重塑中的作用,我们建立了小鼠ATRAP-cDNA转基因小鼠,并检测了聚乙烯袖带置入诱导的炎性血管损伤后的重塑。在ATRAP转基因小鼠(ATRAP-TG)中,ATRAP mRNA在心脏、主动脉和股动脉中增加了3-4倍。ATRAP-TG小鼠在体重、收缩压、心率和心体比方面没有明显变化。然而,ATRAP-TG组小鼠损伤动脉的细胞增殖和新生内膜形成减少。ATRAP-TG小鼠放置袖带后NADPH氧化酶活性的升高和NADH/NADPH氧化酶亚基p22^<;Phox>;的表达也减弱。此外,ATRAP-TG小鼠放置袖带后细胞外信号调节激酶(ERK)、信号转导和转录激活因子(STAT)1和STAT3的激活显著减少。此外,我们还观察到压力超负荷和血管紧张素Ⅱ输注引起的心肌肥厚在ATRAP-TG小鼠中被减弱,在ATRAP-TG小鼠中对血管紧张素II的升压反应也降低。这些结果提示,ATRAP作为一种负性调节因子在心血管重构中起着重要作用。
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan
- DOI:10.1161/01.hyp.0000113627.08110.6f
- 发表时间:2004-02-01
- 期刊:
- 影响因子:8.3
- 作者:Jinno, T;Iwai, M;Horiuchi, M
- 通讯作者:Horiuchi, M
Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules
- DOI:10.1038/sj.ki.5000130
- 发表时间:2006-02-01
- 期刊:
- 影响因子:19.6
- 作者:Tsurumi, Y;Tamura, K;Umemura, S
- 通讯作者:Umemura, S
Oishi, Y., Ozono, R., Yano, Y., Teranishi, Y., Akishita, M., Horiuchi, M., et al.: "Cardioprotective role of AT2 receptor in post-infarction left ventricular remodeling"Hypertension. 41. 814-818 (2003)
Oishi, Y.、Ozono, R.、Yano, Y.、Teranishi, Y.、Akishita, M.、Horiuchi, M.等人:“AT2 受体在梗塞后左心室重塑中的心脏保护作用”高血压。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of combination of calcium channel blocker, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.
钙通道阻滞剂阿折地平和 AT1 受体阻滞剂奥美沙坦联合使用对载脂蛋白 E 缺陷小鼠动脉粥样硬化的影响。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Suzuki;J.;Iwai;M.;Li;Z.;Li;J-M.;Min;LJ.;Ide;A.;Yoshii;T.;et al.
- 通讯作者:et al.
The novel angiotensinII typel receptor(AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
新型血管紧张素II型受体(AT1R)相关蛋白ATRAP下调AT1R并改善心肌细胞肥大。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Tanaka;Y.;Tamira;K.;Koide;Y.;Sakai;M.;Tsurumi;Y.;Noda;Y.;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORIUCHI Masatsugu其他文献
HORIUCHI Masatsugu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORIUCHI Masatsugu', 18)}}的其他基金
Roles of Angiotensin II Receptor-Associated Protein in Vascular Senescence
血管紧张素 II 受体相关蛋白在血管衰老中的作用
- 批准号:
21390242 - 财政年份:2009
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New Therapeutic Approach Using Novel Nuclear Translocating Signaling Protein Against Vascular Remodeling and Atherosclerosis
使用新型核转位信号蛋白对抗血管重塑和动脉粥样硬化的新治疗方法
- 批准号:
18390235 - 财政年份:2006
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism vascular remodeling and blood pressure regulation by orphan receptor, and theraputic
孤儿受体血管重塑和血压调节的分子机制及治疗
- 批准号:
12557064 - 财政年份:2000
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cross-talk between angiotensin II receptor and cytokines in vascular disease
血管疾病中血管紧张素 II 受体与细胞因子之间的相互作用
- 批准号:
12470156 - 财政年份:2000
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
10386279 - 财政年份:2021
- 资助金额:
$ 9.22万 - 项目类别:
Prevention of the secondary cerebral organ damage by stimulation of the AT2-receptor and the receptor Mas in a model of acute lung injury
刺激AT2受体和Mas受体预防急性肺损伤模型继发性脑器官损伤
- 批准号:
423491678 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Research Grants
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
10312024 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
10741585 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
10528244 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
10536595 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:
MC_PC_19023 - 财政年份:2019
- 资助金额:
$ 9.22万 - 项目类别:
Intramural
Understanding the cardio-protective actions of the AT2R in females: Shifting gears between AT1 and AT2 receptor balance of function with relaxin.
了解 AT2R 对女性的心脏保护作用:通过松弛素在 AT1 和 AT2 受体功能平衡之间切换。
- 批准号:
nhmrc : GNT1101552 - 财政年份:2016
- 资助金额:
$ 9.22万 - 项目类别:
Project Grants
Understanding the cardio-protective actions of the AT2R in females: Shifting gears between AT1 and AT2 receptor balance of function with relaxin.
了解 AT2R 对女性的心脏保护作用:通过松弛素在 AT1 和 AT2 受体功能平衡之间切换。
- 批准号:
nhmrc : 1101552 - 财政年份:2016
- 资助金额:
$ 9.22万 - 项目类别:
Project Grants
Improvement of cognitive decline by cerebral AT2 receptor and HDAC2 inhibition
通过大脑 AT2 受体和 HDAC2 抑制改善认知能力下降
- 批准号:
15K19974 - 财政年份:2015
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)